Photodynamic therapy, formulation usable for this purpose, and method for the production and use thereof
Photodynamic therapy of tumors such as bladder tumors includes photosensitizing with a photosensitizer that is a complex or a compound of hypericin and a polymeric complexing agent. The photosensitizer is formed from an alkali salt of hypericin and the polymeric complexing agent. The alkali salt of hypericin is a sodium salt or a potassium salt. The complexing agent is a polyethylene glycol or a poly-N-vinyl amide.
1. A method for photodynamic therapy of tumors, comprising:
photosensitizing with a photosensitizer that is a lyophilizate obtained from a stable complex or a stable compound of an alkali salt of hypericin and a polymeric complexing agent in a buffer system of a phosphate buffer or a citric acid buffer,
wherein the photosensitizer contains 0.225 mg of hypericin.
2. The method according to claim 1 , wherein the alkali salt of hypericin is a sodium salt or a potassium salt.
3. The method according to claim 2 , wherein a photodynamic therapy of bladder cancer is made.
4. The method according to claim 2 , wherein the photosensitizer has a concentration of of 9 to 40 μM of hypericin, and the method further comprises applying light at light intensities of 5 to 25 mW/cm 2 at wavelengths of visible light in a yellow, orange and/or red spectral range.
5. The method according to claim 1 , wherein the photosensitizer has a concentration of 9 to 40 μM of hypericin.
6. The method according to claim 1 , further comprising:
applying light at an intensity of of 5 to 25 mW/cm 2 at wavelengths of visible light in a yellow, orange and/or red spectral range.
7. The method according to claim 1 , further comprising instillation times of 15 to 120 minutes.
8. The method according to claim 1 , wherein the complexing agent is a polyethylene glycol or a poly-N-vinyl amide.
9. The method according to claim 8 , wherein poly-N-vinyl amide is a polyvinylpyrrolidone (PVP) of various degrees of polymerization and cross-linking.
10. The method according to claim 9 , wherein the polyvinylpyrrolidone is PVP k17, PVP k25 or PVP k30.
11. A method for photodynamic therapy of cancer or bladder cancer, comprising:
photosensitizing with a photosensitizer that is a lyophilizate obtained from a stable complex or a stable compound of an alkali salt of hypericin and a polymeric complexing agent in a buffer system of a phosphate buffer or a citric acid buffer,
wherein the photosensitizer contains 0.225 mg of hypericin.
12. A method for photodynamic therapy of tumors, comprising:
photosensitizing with a photosensitizer that is a stable complex or a stable compound of a sodium or potassium salt of hypericin and a polymeric complexing agent selected from the group consisting of polyethylene glycol and poly-N-vinyl amide, wherein the photosensitizer is obtained from a lyophilisate obtained from a solution of the sodium or potassium salt of hypericin, containing 0.0225 mg hypericin/g solution, the polymeric complexing agent and a buffer system comprising a phosphate buffer or a citric acid buffer,
wherein the solution has been lyophilized to obtain the photosensitizer containing 0.225 mg of hypericin.
13. The method according to claim 12 , wherein the photosensitizer has a concentration of 9 to 40 μM of hypericin.
14. The method according to claim 12 , further comprising:
applying light at an intensity of 5 to 25 mW/cm 2 at wavelengths of the visible light in a yellow, orange and/or red spectral range.
15. The method according to claim 12 , further comprising instillation times of 15 to 120 minutes.
16. The method according to claim 12 , wherein poly-N-vinyl amide is a polyvinylpyrrolidone (PVP) of various degrees of polymerization and cross-linking.
17. The method according to claim 16 , wherein the polyvinylpyrrolidone is PVP k17, PVP k25 or PVP k30.
18. The method according to claim 12 , wherein a photodynamic therapy of bladder cancer is made.
19. The method according to claim 12 , wherein the photosensitizer has a concentration of of 9 to 40 μM of hypericin, and the method further comprises applying light at light intensities of 5 to 25 mW/cm 2 at wavelengths of visible light in a yellow, orange and/or red spectral range.
20. A method for photodynamic therapy of cancer, comprising:
photosensitizing with a photosensitizer that is a stable complex or a stable compound of a sodium or potassium salt of hypericin and a polymeric complexing agent selected from the group consisting of polyethylene glycol and poly-N-vinyl amide, wherein the photosensitizer is obtained from a lyophilisate obtained from a solution of the sodium or potassium salt of hypericin, containing 0.0225 mg hypericin/g solution, the polymeric complexing agent and a buffer system comprising a phosphate buffer or a citric acid buffer,
wherein the solution has been lyophilized to obtain the photosensitizer containing 0.225 mg of hypericin.